CN4102840
Cancer Australia has agreed to be a sponsor of the event at the Turquoise level for $20,000.00 (GST exclusive). Sponsorship of the ACORD Workshop supports the implementation of the Australian Cancer Plan, namely, Action 4.2.2 to ensure targeted and innovative research investment into areas of unmet and emerging need; improve clinical trial design, including methods to improve equitable access to trials; and accelerate translation of innovative research into clinical practice. Through this sponsorship opportunity, Cancer Australia was able to promote the Australian Comprehensive Cancer Network and efforts in embedding culturally safe cancer care in research.
Cancer Australia contracted Medical Oncology Group of Australia for AU$22,000 in sponsorship category (limited tender). The agreement ran for five days in September 2024 and supported the ACORD Workshop, advancing implementation of the Australian Cancer Plan through targeted research investment, improved clinical trial design, and translation of innovative research into clinical practice.
Contract Details
- Contract ID
- CN4102840
- Status
- active
- Financial Year
- FY25
- Category
- Management and Business Services(UNSPSC: 80141609)
Key Dates
- Publish Date
- 21 Oct 2024
- Signed Date
- 21 Oct 2024
- Start Date
- 21 Sept 2024
- End Date
- 26 Sept 2024
- Duration
- 0 month
Procurement Information
- Procurement Method
- Limited tender
Supplier
MEDICAL ONCOLOGY GROUP OF AUSTRALIA
- ABN
- 94 601 175 669
- Entity Type
- Other Incorporated Entity
- Location
- NSW